Related Experiment Video
Updated: Mar 11, 2026
09:03
Monitoring Functionality and Morphology of Vasculature Recruited by Factors Secreted by Fast-growing Tumor-generating Cells
Published on: November 23, 2014
10.2K
Morphological Aspects of Tumor Angiogenesis
Ruslan Hlushchuk1, Sébastien Barré2, Valentin Djonov2
1Institute of Anatomy, University of Bern, Baltzerstrasse 2, 3000, Bern, Switzerland. ruslan.hlushchuk@ana.unibe.ch.
Methods in Molecular Biology (Clifton, N.J.)
|November 19, 2016
Summary
Tumor vasculature exhibits chaotic, disorganized vessels lacking hierarchical structure. These abnormal tumor vessels are fragile, leaky, and feature irregular contours, differing significantly from normal tissue vasculature.
Area of Science:
- Oncology
- Vascular Biology
- Biomedical Engineering
Background:
- Tumor vasculature significantly deviates from normal tissue vasculature in organization, structure, and function.
- Abnormalities include heterogeneous vessel wall composition and a lack of pericytes, leading to vessel fragility and leakiness.
Purpose of the Study:
- To elucidate the structural and organizational abnormalities characterizing tumor vasculature.
- To highlight the key differences between tumor and normal tissue blood vessels.
Main Methods:
- Comparative analysis of tumor and normal tissue vasculature.
- Histological and architectural assessment of vessel networks.
Main Results:
- Tumor vessels display a chaotic, hierarchically disorganized structure.
- Common features include irregular vessel contours, heterogeneous distribution, and absence of hierarchical organization.
- Lack of pericytes contributes to vessel fragility and leakiness.
Conclusions:
- Tumor vasculature is fundamentally abnormal in its architecture and cellular composition.
- These vascular abnormalities contribute to tumor progression and present therapeutic challenges.
Related Concept Videos
01:10Mechanism of Angiogenesis
7.4K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
7.4K
01:24Regulation of Angiogenesis and Blood Supply
3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
02:17The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K
02:53Adaptive Mechanisms in Cancer Cells
7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
02:07Tumor Progression
7.7K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.7K
02:30Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K